Summary & Overview
CPT 88720: Noninvasive Bilirubin Measurement, Technical Assay
CPT code 88720 represents a noninvasive laboratory test that measures bilirubin levels without skin puncture, producing a numeric result or range. This code is used for transcutaneous or other technical bilirubin assays commonly employed in neonatal screening and ambulatory bilirubin monitoring. Nationally, accurate coding for 88720 matters for clinical workflows, newborn care quality measures, and consistency in laboratory billing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what 88720 denotes clinically, typical sites of service where it is performed, and context relevant to laboratory service lines. The publication also addresses benchmarking and reimbursement context where available, common modifiers associated with laboratory services, and coding considerations that affect claim adjudication and reporting.
This summary equips billing managers, laboratory directors, and policy analysts with a concise reference to the clinical purpose of 88720, payer coverage scope, and the types of operational and coding topics discussed in the full publication. Data not available in the input will be noted in the relevant sections of the report.
Billing Code Overview
CPT code 88720 describes a noninvasive bilirubin measurement in which a laboratory analyst performs the technical test to determine the amount of bilirubin without puncturing the skin. The result is reported as a numeric value or a numeric range.
Service type: Laboratory — noninvasive bilirubin measurement (transcutaneous/technical assay)
Typical site of service: Hospital outpatient department, clinic, neonatal nursery, or other ambulatory care settings where bedside or point-of-care transcutaneous bilirubin testing is performed.
Clinical & Coding Specifications
Clinical Context
A newborn in the well-baby nursery at a community hospital undergoes routine screening for neonatal jaundice. The nurse performs a transcutaneous bilirubin measurement using a handheld device while the infant is calm and not under phototherapy. The lab analyst or technician documents a numeric bilirubin value (mg/dL) in the electronic medical record and communicates the result to the attending pediatrician. If the transcutaneous reading is elevated or near treatment thresholds, the clinician may order a confirmatory serum total bilirubin (venous or capillary) and consider phototherapy or further evaluation for hemolysis, infection, or metabolic causes. Typical workflow steps: device calibration and quality control by lab personnel, bedside transcutaneous measurement by nursing or trained technician, entry of the numeric result into the chart, and physician review for clinical decision-making.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing for physician interpretation or oversight of the test result separated from the technical component |
TC | Technical component | When billing for the equipment, supplies, and technical performance only (laboratory/clinic) |